FIELD: medicine.
SUBSTANCE: present invention relates to novel method, composition and kit applicable for treating pulmonary diseases, such as pulmonary arterial hypertension. In particular, composition iloprost are provided, which can be aerosolized, which are intended for use in inhalation therapy. Their introduction represents bolus inhalation, which is convenient for patient, effective and well tolerable.
EFFECT: bolus inhalation can be achieved, for example, using efficient nebulizer, based on vibrating screen technology.
18 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
USING GLUCOCORTICOID COMPOSITION FOR TREATING SEVERE AND UNCONTROLLED ASTHMA | 2010 |
|
RU2519344C2 |
INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
TREATMENT OF PULMONARY INFECTIONS BY ADMINISTERING TOBRAMYCIN BY AEROLYSATION | 2011 |
|
RU2597842C2 |
INHALER DEVICE FOR USE IN AEROSOL THERAPY OF RESPIRATORY DISEASES | 2015 |
|
RU2700650C2 |
DELIVERY OF ALPHA-1 INHIBITOR OF PROTEINASE INTO LUNGS | 2007 |
|
RU2433841C2 |
METHOD FOR DELIVERING AEROSOL OF LARGE THERAPEUTIC MASS IN HIGHLY EFFECTIVE MODE | 2001 |
|
RU2275900C2 |
METHOD OF PREVENTING BRONCHOPULMONARY DYSPLASIA IN NEWBORN BABIES WITH VERY LOW AND EXTREMELY LOW BODY WEIGHT AT BIRTH | 2009 |
|
RU2416388C1 |
ALPHA-1 PROTEINASE INHIBITOR FOR DELAY OF BEGINNING OR PROGRESS OF PULMONARY EXACERBATIONS | 2012 |
|
RU2635482C2 |
DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE | 2006 |
|
RU2421209C2 |
Authors
Dates
2016-12-27—Published
2012-04-26—Filed